91 related articles for article (PubMed ID: 1449604)
1. Molecular close-packing method and its application to crystal structure determination of deshexapeptide (B25-B30) insulin.
Ren Z; Liang DC
Sci China B; 1992 Jul; 35(7):783-90. PubMed ID: 1449604
[TBL] [Abstract][Full Text] [Related]
2. The crystal structure of deshexapeptide (B25-B30) insulin at 0.25 nm resolution.
Chang W; Jiang T; Ren Z; Wan Z; Xu Y; Liang D; Zhu S; Zhang Y
Sci China B; 1995 Sep; 38(9):1094-100. PubMed ID: 8554678
[TBL] [Abstract][Full Text] [Related]
3. I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.
Whittingham JL; Youshang Z; Záková L; Dodson EJ; Turkenburg JP; Brange J; Dodson GG
Acta Crystallogr D Biol Crystallogr; 2006 May; 62(Pt 5):505-11. PubMed ID: 16627943
[TBL] [Abstract][Full Text] [Related]
4. Preliminary crystallographic analysis of deshexapeptide (B25-B30) insulin.
Wan ZL; Lou MZ; Liang DC; Zhu SG; Cao QP; Zhang YS
Sci China B; 1990 Aug; 33(8):964-7. PubMed ID: 2242220
[TBL] [Abstract][Full Text] [Related]
5. Structure of monomeric porcine DesB1-B2 despentapeptide (B26-B30) insulin at 1.65 A resolution.
Diao JS; Wan ZL; Chang WR; Liang DC
Acta Crystallogr D Biol Crystallogr; 1997 Sep; 53(Pt 5):507-12. PubMed ID: 15299880
[TBL] [Abstract][Full Text] [Related]
6. Studies on the crystal structure of [L-Met]B0 bovine insulin at 3.0A resolution.
Song HW; Chang WR; Liang DC
Sci China B; 1993 Feb; 36(2):187-95. PubMed ID: 8318150
[TBL] [Abstract][Full Text] [Related]
7. Molecular replacement studies on crystal structure of DesB1-B2 Despentapeptide (B26-B30) insulin.
Diao J; Wan Z; Chang W; Liang D
Sci China C Life Sci; 1997 Oct; 40(5):524-30. PubMed ID: 20229305
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure determination of desheptapeptide (B24--B30)-insulin.
Wang DC; Lu GG; Zhang JP; Xie DL; Chang WR; Lu ZX; Liang DC
Sci China B; 1989 Feb; 32(2):155-65. PubMed ID: 2673287
[TBL] [Abstract][Full Text] [Related]
9. Crystallization force--a density functional theory concept for revealing intermolecular interactions and molecular packing in organic crystals.
Li T; Ayers PW; Liu S; Swadley MJ; Aubrey-Medendorp C
Chemistry; 2009; 15(2):361-71. PubMed ID: 19034948
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of a prolonged-acting insulin with albumin-binding properties.
Whittingham JL; Havelund S; Jonassen I
Biochemistry; 1997 Mar; 36(10):2826-31. PubMed ID: 9062110
[TBL] [Abstract][Full Text] [Related]
11. Studies on the crystal structure of A1-(D-Tryptophan) insulin.
Wan ZL; Liang DC
Sci China B; 1990 Jul; 33(7):810-20. PubMed ID: 2282147
[TBL] [Abstract][Full Text] [Related]
12. [X-ray structural study of the crystalline structure of human progastricsin by a molecular replacement method].
Fedorov AA; Chernaia MM; Strokopytov BV; Nikitenko AV; Fonarev IuD; Kuzin AP
Bioorg Khim; 1993 Jan; 19(1):33-42. PubMed ID: 8484812
[TBL] [Abstract][Full Text] [Related]
13. The solution structure of a superpotent B-chain-shortened single-replacement insulin analogue.
Kurapkat G; Siedentop M; Gattner HG; Hagelstein M; Brandenburg D; Grötzinger J; Wollmer A
Protein Sci; 1999 Mar; 8(3):499-508. PubMed ID: 10091652
[TBL] [Abstract][Full Text] [Related]
14. The solution structure of a monomeric insulin. A two-dimensional 1H-NMR study of des-(B26-B30)-insulin in combination with distance geometry and restrained molecular dynamics.
Knegtel RM; Boelens R; Ganadu ML; Kaptein R
Eur J Biochem; 1991 Dec; 202(2):447-58. PubMed ID: 1761045
[TBL] [Abstract][Full Text] [Related]
15. An examination of the role of insulin dimerisation and negative cooperativity using the biological properties of the despentapeptide and deshexapeptide insulins.
Cockram CS; Jones RH; Sonksen PH; Tatnell MA; Zhu SQ; Dodson G
Diabetologia; 1987 Sep; 30(9):733-8. PubMed ID: 3322916
[TBL] [Abstract][Full Text] [Related]
16. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant.
Záková L; Brynda J; Au-Alvarez O; Dodson EJ; Dodson GG; Whittingham JL; Brzozowski AM
Biochemistry; 2004 Dec; 43(51):16293-300. PubMed ID: 15610023
[TBL] [Abstract][Full Text] [Related]
17. On the solution of the molecular-replacement problem at very low resolution: application to large complexes.
Urzhumtsev A; Podjarny A
Acta Crystallogr D Biol Crystallogr; 1995 Nov; 51(Pt 6):888-95. PubMed ID: 15299758
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the method of molecular replacement by incorporation of known structural information.
Zhang XJ; Matthews BW
Acta Crystallogr D Biol Crystallogr; 1994 Sep; 50(Pt 5):675-86. PubMed ID: 15299365
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of an engineered insulin monomer at neutral pH.
Olsen HB; Ludvigsen S; Kaarsholm NC
Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
[TBL] [Abstract][Full Text] [Related]
20. Solution structure of the superactive monomeric des-[Phe(B25)] human insulin mutant: elucidation of the structural basis for the monomerization of des-[Phe(B25)] insulin and the dimerization of native insulin.
Jørgensen AM; Olsen HB; Balschmidt P; Led JJ
J Mol Biol; 1996 Apr; 257(3):684-99. PubMed ID: 8648633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
